Literature DB >> 9049358

The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR.

A M de Roda Husman1, J M Walboomers, A J van den Brule, C J Meijer, P J Snijders.   

Abstract

Sequence analysis of human papillomavirus (HPV) general primer GP5/6 mediated PCR products revealed the presence of short highly conserved sequences adjacent to the 3' ends of both primers. Part of these sequences was used to elongate GP5 and GP6 at their 3' ends to generate the primers GP5+ and GP6+, respectively. Compared with the GP5/6 PCR, GP5+/6+ specific PCR on 22 cloned mucosotropic HPVs revealed an improved HPV detection, reflected by a 10- to 100-fold higher sensitivity and a markedly increased signal to background ratio, especially at the gel level. As determined on purified DNA, the sensitivity of this GP5+/6+ based assay was at the femtogram level for those HPV genotypes which match strongly with the primers (e.g. HPV-16) and at the picogram level for HPV types (e.g. HPV-39 and -51) having four or more mismatches with one or both primers. Application of both methods on 264 cervical scrapes of a cohort of women participating in a prospective follow-up study revealed an increase of total HPV positivity from 39% (GP5/6 PCR) to 43% (GP5+/6+ PCR) of the scrapes. Additional HPV typing by PCR specific for the HPV-6, -11, -16, -18, -31 and -33 revealed that all GP5+/6+ PCR positive cases which were negative by GP5/6 PCR (n = 12) contained HPV types different from these six types. These data indicate that the GP5+/6+ PCR method provides an increased detection level mainly of uncommon, apparently poorly matched HPV types in cervical scrapes and most likely in the enlargement of the spectrum of HPVs detectable by this assay.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9049358     DOI: 10.1099/0022-1317-76-4-1057

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  345 in total

1.  Improved amplification of genital human papillomaviruses.

Authors:  P E Gravitt; C L Peyton; T Q Alessi; C M Wheeler; F Coutlée; A Hildesheim; M H Schiffman; D R Scott; R J Apple
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  A novel strategy for human papillomavirus detection and genotyping with SybrGreen and molecular beacon polymerase chain reaction.

Authors:  K Szuhai; E Sandhaus; S M Kolkman-Uljee; M Lemaître; J C Truffert; R W Dirks; H J Tanke; G J Fleuren; E Schuuring; A K Raap
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

3.  Distribution of 14 high risk HPV types in cervical intraepithelial neoplasia detected by a non-radioactive general primer PCR mediated enzyme immunoassay.

Authors:  I Nindl; B Lotz; R Kühne-Heid; U Endisch; A Schneider
Journal:  J Clin Pathol       Date:  1999-01       Impact factor: 3.411

4.  Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma.

Authors:  E C Pirog; B Kleter; S Olgac; P Bobkiewicz; J Lindeman; W G Quint; R M Richart; C Isacson
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

Review 5.  [HPV-associated squamous cell carcinogenesis].

Authors:  G Assmann; K Sotlar
Journal:  Pathologe       Date:  2011-09       Impact factor: 1.011

6.  Co-expression of metalloproteinases 11 and 12 in cervical scrapes cells from cervical precursor lesions.

Authors:  Alejandra Valdivia; Raúl Peralta; Manuel Matute-González; Juan Manuel García Cebada; Ivonne Casasola; Cristina Jiménez-Medrano; Rogelio Aguado-Pérez; Vanessa Villegas; Cesar González-Bonilla; Leticia Manuel-Apolinar; Miguel Ibáñez; Mauricio Salcedo
Journal:  Int J Clin Exp Pathol       Date:  2011-10-12

7.  Viral and bacterial aetiologies of epithelial ovarian cancer.

Authors:  S Shanmughapriya; G Senthilkumar; K Vinodhini; B C Das; N Vasanthi; K Natarajaseenivasan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-03-09       Impact factor: 3.267

8.  mTOR as a molecular target in HPV-associated oral and cervical squamous carcinomas.

Authors:  Alfredo A Molinolo; Christina Marsh; Mohamed El Dinali; Nitin Gangane; Kaitlin Jennison; Stephen Hewitt; Vyomesh Patel; Tanguy Y Seiwert; J Silvio Gutkind
Journal:  Clin Cancer Res       Date:  2012-03-12       Impact factor: 12.531

9.  A novel and rapid PCR-based method for genotyping human papillomaviruses in clinical samples.

Authors:  J H Nelson; G A Hawkins; K Edlund; M Evander; L Kjellberg; G Wadell; J Dillner; T Gerasimova; A L Coker; L Pirisi; D Petereit; P F Lambert
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

10.  Retrospective analysis of HPV 16/18-related disease burden using archival clinical samples.

Authors:  Naureen Ehsan Ilahi; Shoaib Naiyar Hashmi; Sobia Anwar; Sheeba Murad
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-30       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.